Thoracotomy

Hospital at Home Program Helping Cancer Patients and Their Families With Medical and Financial Support Services

Retrieved on: 
Wednesday, June 29, 2022

Lauren received an osteosarcoma diagnosis, a type of bone cancer that most commonly occurs in the long bones around the knee.

Key Points: 
  • Lauren received an osteosarcoma diagnosis, a type of bone cancer that most commonly occurs in the long bones around the knee.
  • For many patients, the symptoms of osteosarcoma include pain or swelling in the affected bone and decreased mobility of the affected limb.
  • The medical team reconstructed what was removed during the procedure with prosthetics and muscles from other areas of her body.
  • The Hospital at Home service sends trained nurses to the patient's home for chemotherapy, administering medications, and other supportive therapies.

Quick Tube Medical Announces Revolutionary Chest Tubes to hit markets April 8th

Retrieved on: 
Wednesday, March 31, 2021

FLETCHER, N.C., March 31, 2021 /PRNewswire-PRWeb/ --Leaders from Quick Tube Medical have just announced that the Company will begin delivering its one of a kind, FDA-registered standardized chest tube systems on April 8th.

Key Points: 
  • FLETCHER, N.C., March 31, 2021 /PRNewswire-PRWeb/ --Leaders from Quick Tube Medical have just announced that the Company will begin delivering its one of a kind, FDA-registered standardized chest tube systems on April 8th.
  • More than 1 million chest tubes are annually placed in the United States, and more than 4 million are placed worldwide.
  • In general terms, a "chest tube" is also known as a chest drain, thoracic catheter, tube thoracotomy, or intercostal drain.
  • According to Quick Tube Medical co-founder Ryan Luttrell, "Bringing Quick Tube Medical's chest tube to the medical marketplace is the highlight of my healthcare career.

FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device Intended for the Treatment of Severe Heart Failure

Retrieved on: 
Tuesday, May 5, 2020

The results of this preliminary chronic study are extremely promising and set the stage for the next phase of the products development.

Key Points: 
  • The results of this preliminary chronic study are extremely promising and set the stage for the next phase of the products development.
  • Heart failure (HF) is the second leading cause of death in the U.S. and Europe.
  • The ability to support natural heart function through a fully implantable, permanent device would dramatically improve heart failure patient quality of life and long-term outcomes.
  • Simple surgery with implant stability: ICOMS is implanted via mini-thoracotomy through a trans-apical approach into the beating heart without cardiopulmonary bypass.

FDA Approves Less Invasive Surgical Approach for Abbott's Heart Pump to Help Patients Avoid Open Heart Surgery

Retrieved on: 
Tuesday, January 7, 2020

ABBOTT PARK, Ill., Jan. 7, 2020 /PRNewswire/ -- Abbott (NYSE: ABT)today announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical technique for Abbott's HeartMate 3 heart pump that will allow more advanced heart failure patients to avoid open heart surgery.

Key Points: 
  • ABBOTT PARK, Ill., Jan. 7, 2020 /PRNewswire/ -- Abbott (NYSE: ABT)today announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical technique for Abbott's HeartMate 3 heart pump that will allow more advanced heart failure patients to avoid open heart surgery.
  • The new, less invasive approach is designed to provide surgeons a choice in surgical method for patients receiving the HeartMate 3 Left Ventricular Assist Device (LVAD), the industry's leading heart pump.
  • With approval for an alternative surgical technique, Abbott's HeartMate 3 heart pump can now be implanted via lateral thoracotomy a surgical approach where an incision is made between a patient's ribs to access the heart.
  • Physicians believe that for many patients this technique has advantages over open heart surgery because it can result in less bleeding and a shorter recovery time for patients.